Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
add, adherence, annum, axatilimab, Bank, BID, Biopharma, cardiovascular, cGVHD, Chase, CLL, concurrently, customary, Cycle, daily, double, EADV, ear, eosinophil, equitable, Eurodollar, exert, facial, fear, forma, formulary, guarantor, guaranty, IGA, Index, injectable, InnoCare, loan, lt, maximum, minimum, MINJUVI, moratorium, Morgan, myelosuppression, nonhematologic, NRS, OECD, OPZELURA, Organisation, outline, partial, Pharma, PR, pre, prurigo, ratio, Rescue, rest, revolving, rhinorrhea, Sprl, step, stricter, Sunny, Syndax, taxation, thromboembolic, tumour, UCB, undrawn, unsecured, urticaria, Venereology, warm, withdrew, withholding
Removed:
capitalizing, improving, MPN, RAD, Revolutionizing, stay, symposium, Trump
Valuein 2020 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view